IAVI

News

CEPI puts $60m behind three Ebola vaccine candidates

Moderna has been awarded $50m from CEPI for a Bundibugyo ebolavirus vaccine candidate, with funding also made available to two other candidates.

News

Merck & Co and IAVI join forces to develop COVID-19 vaccine

Merck & Co has joined with the non-profit scientific research organisation, the International AIDS Vaccine Initiative (IAVI), to develop a potential vaccine against the SARS-CoV-2 coron

R&D

pharmaphorum podcast with IAVI on global health challenges

Addressing global health challenges: the pharmaphorum podcas...

For episode 11 of the pharmaphorum podcast our CEO and founder Dr Paul Tunnah took the helm to record a special roundtable episode in Philadel

CEPI puts $60m behind three Ebola vaccine candidates

Merck & Co and IAVI join forces to develop COVID-19 vaccine

Addressing global health challenges: the pharmaphorum podcas...

ASCO 2026: Chinese firms take a front seat in oncology, with...

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks